Pathway analyses were predominantly performed on the 50 hallmark pathways described in the molecular signature database. To assign pathway activity estimates to individual cells, we applied GSVA 71 using standard settings, as implemented in the GSVA package (Version 1.30.0). Differential activated pathways between cells from tumor and nontumor tissues were tested using the generalized linear model from the Limma package (Version 3.38.3), and P‐values were Benjamini‐Hochberg‐corrected. Pathways with adjusted P‐value < .05 were considered to be significantly differentially activated. Tumor features, cell cycle, EMT, invasion, and metastasis, were quantified using genes involved in these pathways by GSVA (Table S5).

Note: The content above has been extracted from a research article, so it may not display correctly.

Please log in to submit your questions online.
Your question will be posted on the Bio-101 website. We will send your questions to the authors of this protocol and Bio-protocol community members who are experienced with this method. you will be informed using the email address associated with your Bio-protocol account.

We use cookies on this site to enhance your user experience. By using our website, you are agreeing to allow the storage of cookies on your computer.